These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26743531)

  • 1. Ovarian cancer outcomes: Predictors of early death.
    Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
    Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study.
    Melamed A; Fink G; Wright AA; Keating NL; Gockley AA; Del Carmen MG; Schorge JO; Rauh-Hain JA
    BMJ; 2018 Jan; 360():j5463. PubMed ID: 29298771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year relative survival for epithelial ovarian cancer.
    Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
    Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
    Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
    Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer.
    Wright JD; Ananth CV; Tsui J; Glied SA; Burke WM; Lu YS; Neugut AI; Herzog TJ; Hershman DL
    Cancer; 2014 Apr; 120(8):1246-54. PubMed ID: 24443159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
    Gockley A; Melamed A; Bregar AJ; Clemmer JT; Birrer M; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Obstet Gynecol; 2017 Mar; 129(3):439-447. PubMed ID: 28178043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
    Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
    Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
    Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
    Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis.
    Vogel TJ; Jeon C; Karlan B; Walsh C
    Gynecol Oncol; 2016 Feb; 140(2):285-8. PubMed ID: 26691221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of intraperitoneal chemotherapy for optimally cytoreduced advanced stage epithelial ovarian cancer: A 10-year single institution experience with a racially diverse urban population.
    Miller EM; Tymon-Rosario J; Xie X; Xue X; Gressel GM; Miller DT; Kuo DY; Nevadunsky NS
    Gynecol Oncol; 2017 Oct; 147(1):36-40. PubMed ID: 28751119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.
    Warren JL; Harlan LC; Trimble EL; Stevens J; Grimes M; Cronin KA
    Gynecol Oncol; 2017 Jun; 145(3):486-492. PubMed ID: 28372872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term mortality among women with epithelial ovarian cancer.
    Dinkelspiel HE; Champer M; Hou J; Tergas A; Burke WM; Huang Y; Neugut AI; Ananth CV; Hershman DL; Wright JD
    Gynecol Oncol; 2015 Aug; 138(2):421-8. PubMed ID: 26050923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
    Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
    Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.